SLC5A2 and type 2 diabetes mellitus: Indeed, MEMRI is currently being used in a trial to assess the impact of an SGLT-2 inhibitor on calcium handling in patients with symptomatic HF with and without T2D (NCT04591639) and a randomized controlled trial will assess the role of diet and exercise on calcium handling in obese patients with T2D [117].